QUARAOffering
Convertible note pays 10% per year. Minimum investment $10,000
Convertible note pays 10% per year. Minimum investment $10,000
The capital raising process completed on March 29th. Listing on the OTCQX is planned.
TransCode is a pre-clinical biopharmaceutical company focused on the development and commercialization of therapeutics to treat metastatic cancer.
Bringing Trust to the $120 billion Skincare Industry
Develops targeted anti-cancer chemotherapy drugs with improved efficacy and lower side effects, currently in clinical trials at the Mayo Clinic.
to capital through the ability to raise up to $75 million, but also a greater ... provisions, hindering the issuer’s future capital raising activities. Alabama’s ...